Copyright
©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 696-707
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.696
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.696
Marker | Parameters | Performance in S. mansoni infected patients | |||||
Severe PPF | Mild/significant PPF | ||||||
Cut-off | Sn (%) | Sp (%) | Cut-off | Sn (%) | Sp (%) | ||
Platelet count[17,26] | Platelet count/mm3 | 141000[17] | 78.5 | 60 | 171000[17], 108500[26] | 80, 91 | 91.7, 85 |
APRI[17,26] | (AST/ULN)/platelet count | 1.066 | 58.5 | 71.1 | 0.349[17], 0.440[26] | 90, 96 | 83.3, 85 |
GGT[17] | GGT/ULN | > 1.55 | 60.0 | 75.6 | > 0.84 | 74.6 | 83.3 |
Coutinho index[29,30] | (ALP/ULN)/platelet count | ≥ 0.330[29], ≥ 0.316[30] | 98, 67.4 | 94.7, 68.3 | ≥ 0.300, ≥ 0.228 | 70.8, 68.6 | 89.5, 46.3 |
- Citation: Santos JC, Pereira CLD, Domingues ALC, Lopes EP. Noninvasive diagnosis of periportal fibrosis in schistosomiasis mansoni: A comprehensive review. World J Hepatol 2022; 14(4): 696-707
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/696.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.696